Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Stiff Extracellular Matrix Rejuvenates Aged Mesenchymal Stem Cells via PI3K-AKT Signaling.

Created on 02 Nov 2026

Authors

Wenlong Wang, Kai Pan, Andy X Li, Kaixuan Zhang, Bowen Xu, Xiaoniao Chen, Zongjin Li, Jun Yang

Published in

Advanced healthcare materials. Nov 01, 2026. Epub Nov 01, 2026.

Abstract

Mesenchymal stem cells (MSCs) are widely used to modulate immune responses and promote tissue regeneration, but cellular senescence significantly impairs their therapeutic potential. MSCs undergo senescence characterized by an enlarged morphology, reduced proliferative capacity, and altered expression of genes related to the cytoskeleton. This study revealed that the mechanical microenvironment critically regulates MSC aging. Culturing senescent MSCs on high-stiffness extracellular matrix (ECM) hydrogels reverses key aspects of the senescent phenotype, including the restoration of normal morphology, improved cytoskeletal integrity, and enhanced proliferation. This mechanical rescue is accompanied by genetic reprogramming and activation of the PI3K-AKT signaling pathway. The inhibition of PI3K-Akt with LY294002 abolished these rejuvenating effects. These findings demonstrate that the mechanical microenvironment can reprogram senescent MSCs through PI3K-AKT-mediated mechanotransduction, offering a novel strategy to restore stem cell function in aging and regenerative medicine.

PMID:
42967875
Bibliographic data and abstract were imported from PubMed on 02 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement